Icra sees pharma industry growth tapering to 7-10% over FY18-FY20Post published:July 4, 2017Post category:Industry NewsThe Indian pharma industry is likely to witness a slowdown in growth because of pricing pressure and regulatory interventions in the US, according to an Icra report Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndoStar Capital close to acquiring ICICI Home Finance Next PostGST rates: Footwear to cost more as firms look to increase prices by 5-7% You Might Also Like Microchip Technology releases MXT1067TD, MXT1189TD and MXT1665TD maXTouch touchscreen controllers June 28, 2019 Axiomtek announces PICO316 pico-ITX motherboard February 14, 2018 New India Assurance, GIC set to file for IPO in next three weeks July 27, 2017
Microchip Technology releases MXT1067TD, MXT1189TD and MXT1665TD maXTouch touchscreen controllers June 28, 2019